Bendit Overview
Bendit Technologies is a medical device company developing solutions for steerable microcatheters, providing surgeons with 3D-controlled bending and navigation capabilities for peripheral vascular, neurovascular, and cardiology indications. The companys patented technology reduces the complex catheterization procedure to a single step and enables radial access to reduce patient risk. Bendit Technologies has already received the CE mark and FDA approval for its microcatheter with an indication for peripheral use, and the company will be submitting the Bendit microcatheter for the neurovascular indication in the near future.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
BENDIT Technologies Announces First-in-World Successful Neurointerventional Procedure
BENDIT Technologies announced the successful results of the first-ever use of their BENDIT neuro microcatheter in a life-saving procedure at Sheba Medical Center in Israel. The procedure was performed on a patient with a massive brain aneurysm and was deemed a success. The BENDIT steerable microcatheter allows doctors to deliver treatment quickly and precisely. The CEO of BENDIT Technologies highlighted the importance of their device in providing endovascular intervention for hard-to-access organs. The company has already received FDA and CE Mark for their microcatheter and plans to submit it for the neurovascular indication in the future.
Customers
growth-positive
Bendit Technologies Announces Senior Management Appointments
Bendit Technologies has appointed Richard Cappetta as Chairman of the Board and Yossi Mazel as the new CEO. Cappetta brings extensive experience in the less-invasive medical device business, while Mazel has management and sales experience in the medical devices industry. Bendit Technologies develops breakthrough technologies for steerable microcatheters, aiming to provide surgeons with greater flexibility and accuracy in interventional procedures. The company has already received FDA and CE Mark for its microcatheter with an indication for peripheral use. The appointments of Cappetta and Mazel are expected to contribute to the companys success and commercialization of its innovative microcatheters.
Management Changes
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $6.75M |
| Last funding | $6.75M |
| Stage | Mature |
| Rounds | 1 |
| Investors | 1 |
Team Members
6
Employees: 11-50
Web & Social Links
| Website | www.bendittech.com |
Locations
Basel Street 25, Petah Tikva, Israel
Photos & Videos
1 item(s)
